Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,841 companies covered, latest filing Oct 23.

  • $79.2M bought by 61 insiders at 47 companies
  • $239M sold by 49 insiders outside a trading plan
  • $2.5B sold by 203 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

  1. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    1,430,631 shares at $34.37 Oct 15–21, 5 filings +1.1% to stake 2 superinvestors bought in Q2
    $49.2M
  2. DOLEDole PLC
    Pale Fire Capital SE10% owner, +4 joint filers
    648,356 shares at $13.19 Oct 20–22 +6.7% to stake
    $8.6M
  3. APLDApplied Digital
    Jason Gechen ZhangPresident
    300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2
    $5.7M
  4. RENTRent the Runway
    STORY3 Capital Partners, LLCDirector, +3 joint filers
    632,922 shares at $3.55 Oct 21 +15% to stake
    $2.2M
  5. RENTRent the Runway
    CHS US Investments LLC10% owner, +4 joint filers
    458,245 shares at $3.55 Oct 21 +2% to stake
    $1.6M
  6. FBKFB Financial
    Orrin H Ingram IIDirector
    29,081 shares at $52.88 Oct 20 +31% to stake
    $1.5M
  7. TENXTenax Therapeutics
    ADAR1 Capital Management, LLC10% owner, +1 joint filer
    922,849 shares at $1.59 Oct 19–21 +14% to stake
    $1.5M
  8. APLDApplied Digital
    Wes CumminsCEO
    55,803 shares at $18.04 Oct 16 +1% to stake 5 superinvestors bought in Q2
    $1M
  9. RAPPRapport Therapeutics
    Steven M PaulDirector
    35,714 shares at $27.28 Oct 22 +86% to stake
    $974K
  10. SNESSenesTech
    Glenbrook Capital Management10% owner
    1,087,679 shares at $0.7200 Oct 15–22, 2 filings
    $781K

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)
    $2B
  2. SNOWSnowflake
    Frank SlootmanDirector
    300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)
    $94.9M
  3. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake
    $85.9M
  4. TRVTravelers
    Alan D SchnitzerCEO
    88,900 shares at $396.77 Oct 21 23% of stake
    $35.3M
  5. PATHUiPath
    Daniel DinesCEO
    2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)
    $33.1M
  6. UTHRUnited Therapeutics
    Martine A RothblattCEO
    47,500 shares at $555.06 Oct 16–22, 5 filings 13% of stake Planned sale (10b5-1)
    $26.4M
  7. MUMicron Technology
    Scott J DeboerPres. & Chief Tech & Prod Offr
    28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)
    $25.7M
  8. ALMRAlamar Biosciences
    Qiming Corporate GP VI, Ltd.10% owner, +6 joint filers
    733,811 shares at $28.64 Oct 15–22, 3 filings 29% of stake
    $21M
  9. SNOWSnowflake
    Benoit DagevilleDirector
    50,000 shares at $321.74 Oct 21 2.1% of stake Planned sale (10b5-1)
    $16.1M
  10. LINDLindblad Expeditions
    Sven-Olof LindbladDirector
    403,674 shares at $35.31 Oct 16–22, 2 filings 3.8% of stake Planned sale (10b5-1)
    $14.3M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

FFIV insider trades

Every open-market buy and sale in FFIV, one row per filing, newest first

FFIV page
All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. John Anthony Maddison Chief Product Mkting Officer
    FFIVF5
    Planned sale
    $83K 204 shares at $406.24 15% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  2. Michael F Montoya Chief Technology Ops Officer
    FFIVF5
    Planned sale
    $1.8M 4,426 shares at $410.16 77% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  3. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $501K 1,208 shares at $414.63 13% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  4. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $1.6M 3,782 shares at $412.44 2.5% of stake
    Traded Aug 5 Filed Aug 6
    ↗
  5. Angelique M Okeke EVP, General Counsel
    FFIVF5
    Planned sale
    $208K 515 shares at $404.49 19% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  6. John Anthony Maddison Chief Product Mkting Officer
    FFIVF5
    Planned sale
    $406K 1,000 shares at $405.85 43% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  7. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $243K 599 shares at $405.92 60% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  8. Kunal Anand Chief Technology Officer
    FFIVF5
    Planned sale
    $159K 392 shares at $404.63 3% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  9. Chad Michael Whalen EVP, Worldwide Sales
    FFIVF5
    Planned sale
    $285K 703 shares at $404.86 3.2% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  10. Nikhil Ramesh Mehta Director
    FFIVF5
    Sale
    $1.6M 4,000 shares at $388.95 36% of stake
    Traded Jul 30 Filed Aug 3
    ↗
  11. Elizabeth Buse Director
    FFIVF5
    Sale
    $399K 1,000 shares at $399.35 17% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  12. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $1M 2,500 shares at $400.00 86% of stake
    Traded Jun 2 Filed Jun 3
    ↗
  13. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $525K 1,500 shares at $350.00 34% of stake
    Traded May 8 Filed May 12
    ↗
  14. Chad Michael Whalen EVP, Worldwide Sales
    FFIVF5
    Planned sale
    $2.2M 6,200 shares at $350.19 23% of stake
    Traded May 8 Filed May 12
    ↗
  15. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $439K 1,328 shares at $330.58 14% of stake
    Traded May 5 Filed May 7
    ↗
  16. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $1.3M 3,783 shares at $337.39 2.5% of stake
    Traded May 5 Filed May 7
    ↗
  17. Angelique M Okeke EVP, General Counsel
    FFIVF5
    Planned sale
    $271K 842 shares at $322.33 29% of stake
    Traded May 4 Filed May 5
    ↗
  18. John Anthony Maddison Chief Product Mkting Officer
    FFIVF5
    Planned sale
    $322K 1,000 shares at $322.33 32% of stake
    Traded May 4 Filed May 5
    ↗
  19. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $193K 599 shares at $322.33 12% of stake
    Traded May 4 Filed May 5
    ↗
  20. Kunal Anand Chief Technology Officer
    FFIVF5
    Planned sale
    $1M 3,123 shares at $322.33 20% of stake
    Traded May 4 Filed May 5
    ↗
  21. Chad Michael Whalen EVP, Worldwide Sales
    FFIVF5
    Planned sale
    $233K 704 shares at $330.30 2.5% of stake
    Traded May 4 Filed May 5
    ↗
  22. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $300K 1,000 shares at $300.00 19% of stake
    Traded Mar 25 Filed Mar 26
    ↗
  23. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $1M 3,334 shares at $300.00 2.2% of stake
    Traded Mar 25 Filed Mar 26
    ↗
  24. Chad Michael Whalen EVP, Worldwide Sales
    FFIVF5
    Planned sale
    $191K 688 shares at $277.05 2.5% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  25. Edward Cooper Werner CFO
    FFIVF5
    Planned sale
    $273K 969 shares at $282.20 15% of stake
    Traded Mar 4 Filed Mar 5
    ↗
  26. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $1.1M 3,755 shares at $283.53 2.4% of stake
    Traded Mar 4 Filed Mar 5
    ↗
  27. Michael L Dreyer Director
    FFIVF5
    Sale
    $866K 3,067 shares at $282.41 70% of stake
    Traded Feb 20 Filed Feb 23
    ↗
  28. Alan Higginson Director
    FFIVF5
    Sale
    $487K 1,770 shares at $275.25 21% of stake
    Traded Feb 19 Filed Feb 20
    ↗
  29. Angelique M Okeke EVP, General Counsel
    FFIVF5
    Planned sale
    $107K 386 shares at $278.32 17% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  30. John Anthony Maddison Chief Product Mkting Officer
    FFIVF5
    Planned sale
    $281K 1,000 shares at $280.66 26% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  31. Kunal Anand Chief Technology Officer
    FFIVF5
    Planned sale
    $105K 377 shares at $278.32 4% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  32. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $361K 1,297 shares at $278.32 14% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  33. Lyra Amber Schramm Chief People Officer
    FFIVF5
    Planned sale
    $56K 199 shares at $281.37 53% of stake
    Traded Feb 3 Filed Feb 5
    ↗
  34. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $875K 3,343 shares at $261.87 29% of stake
    Traded Jan 26 Filed Jan 28
    ↗
  35. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $292K 1,110 shares at $262.73 8.9% of stake
    Traded Jan 20 Filed Jan 22
    ↗
  36. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $294K 1,110 shares at $265.00 8.1% of stake
    Traded Jan 12 Filed Jan 14
    ↗
  37. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $293K 1,110 shares at $263.79 7.5% of stake
    Traded Jan 5 Filed Jan 7
    ↗
  38. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $289K 1,100 shares at $262.86 6.9% of stake
    Traded Dec 29, 2025 Filed Dec 30, 2025
    ↗
  39. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $286K 1,110 shares at $257.90 6.6% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
    ↗
  40. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $294K 1,110 shares at $264.76 6.1% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
    ↗
  41. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $276K 1,110 shares at $248.66 5.8% of stake
    Traded Dec 8, 2025 Filed Dec 10, 2025
    ↗
  42. Alan Higginson Director
    FFIVF5
    Sale
    $310K 1,309 shares at $237.11 13% of stake
    Traded Dec 3, 2025 Filed Dec 4, 2025
    ↗
  43. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $263K 1,110 shares at $236.99 5.5% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  44. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $308K 1,300 shares at $236.99 0.9% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  45. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $261K 1,110 shares at $234.92 5.2% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗
  46. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $252K 1,110 shares at $227.44 4.9% of stake
    Traded Nov 18, 2025 Filed Nov 19, 2025
    ↗
  47. Lyra Amber Schramm Chief People Officer
    FFIVF5
    Planned sale
    $262K 1,062 shares at $246.97 100% of stake
    Traded Nov 4, 2025 Filed Nov 5, 2025
    ↗
  48. Chad Michael Whalen EVP, Worldwide Sales
    FFIVF5
    Planned sale
    $2.4M 9,436 shares at $249.77 27% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  49. Thomas Dean Fountain EVP Global Services & Strategy
    FFIVF5
    Planned sale
    $2.1M 8,318 shares at $249.78 27% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
  50. Francois Locoh-Donou CEO
    FFIVF5
    Planned sale
    $329K 1,300 shares at $252.98 0.9% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,841 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.